JP2022509366A5 - - Google Patents
Info
- Publication number
- JP2022509366A5 JP2022509366A5 JP2021547662A JP2021547662A JP2022509366A5 JP 2022509366 A5 JP2022509366 A5 JP 2022509366A5 JP 2021547662 A JP2021547662 A JP 2021547662A JP 2021547662 A JP2021547662 A JP 2021547662A JP 2022509366 A5 JP2022509366 A5 JP 2022509366A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- pharmaceutically acceptable
- acceptable salt
- alkyl
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862751984P | 2018-10-29 | 2018-10-29 | |
| US62/751,984 | 2018-10-29 | ||
| PCT/US2019/057985 WO2020092139A1 (en) | 2018-10-29 | 2019-10-25 | Novel dipeptide compounds and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022509366A JP2022509366A (ja) | 2022-01-20 |
| JP2022509366A5 true JP2022509366A5 (OSRAM) | 2022-10-20 |
| JP7503561B2 JP7503561B2 (ja) | 2024-06-20 |
Family
ID=70464360
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021547662A Active JP7503561B2 (ja) | 2018-10-29 | 2019-10-25 | 新規ジペプチド化合物及びその使用方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US12209141B2 (OSRAM) |
| EP (1) | EP3873916B8 (OSRAM) |
| JP (1) | JP7503561B2 (OSRAM) |
| KR (1) | KR102882178B1 (OSRAM) |
| CN (2) | CN116813691B (OSRAM) |
| AU (1) | AU2019371209B2 (OSRAM) |
| CA (1) | CA3117599A1 (OSRAM) |
| IL (1) | IL282676B1 (OSRAM) |
| TW (1) | TWI870362B (OSRAM) |
| WO (1) | WO2020092139A1 (OSRAM) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116813691B (zh) * | 2018-10-29 | 2024-04-12 | 丽珠医药集团股份有限公司 | 新的二肽类化合物及其用途 |
| JP2026504578A (ja) * | 2023-02-16 | 2026-02-05 | 浙江華海薬業股▲フン▼有限公司 | ジペプチド類化合物の塩、ならびにその調製方法および使用 |
| CN118496301A (zh) * | 2023-02-16 | 2024-08-16 | 丽珠医药集团股份有限公司 | 一种二肽类化合物的盐、其制备方法和用途 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6087380A (en) | 1949-11-24 | 2000-07-11 | Boehringer Ingelheim Pharma Kg | Disubstituted bicyclic heterocycles, the preparations and the use thereof as pharmaceutical compositions |
| MX9201416A (es) * | 1991-03-28 | 1992-10-01 | Rhone Poulenc Rorer Int | Peptidos y pseudopeptidos antitromboticos. |
| JP4561696B2 (ja) | 1994-01-27 | 2010-10-13 | 三菱化学株式会社 | プロリンアミド誘導体 |
| FR2793248B1 (fr) * | 1999-05-03 | 2001-06-29 | Adir | Nouveaux derives de 2,3-methano-aminoacides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| US6774110B2 (en) | 2001-03-19 | 2004-08-10 | Lg Life Sciences Ltd. | Orally available peptidic thrombin inhibitors |
| FR2836143B1 (fr) | 2002-02-21 | 2004-04-16 | Servier Lab | Nouveaux derives d'acides amines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| US20030181488A1 (en) | 2002-03-07 | 2003-09-25 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester and the salts thereof |
| DE10339862A1 (de) | 2003-08-29 | 2005-03-24 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)- phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester-Methansulfonat und dessen Verwendung als Arzneimittel |
| EP1778616A1 (en) * | 2004-08-09 | 2007-05-02 | Cancer Research Technology Limited | Alpha-ketoglutarates and their use as therapeutic agents |
| DE102004062864A1 (de) | 2004-12-21 | 2006-06-22 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Folienbehälter |
| CN100502914C (zh) * | 2005-10-24 | 2009-06-24 | 丽珠医药集团股份有限公司 | 一种治疗脑中风的中药组合物及其制备方法 |
| KR20080104352A (ko) * | 2006-03-29 | 2008-12-02 | 쉐링 코포레이션 | 트롬빈 수용체 길항제로서 유용한 모노사이클릭 및 비사이클릭 힘바신 유도체 |
| EP2152664B1 (en) * | 2007-06-13 | 2014-09-03 | Bristol-Myers Squibb Company | Dipeptide analogs as coagulation factor inhibitors |
| TWI513466B (zh) | 2010-01-20 | 2015-12-21 | Boehringer Ingelheim Int | 抗凝血劑解毒劑 |
| CN102464701B (zh) * | 2010-11-08 | 2015-10-21 | 上海医药工业研究院 | 一类新型化合物、其制备方法及用途 |
| CN102796168B (zh) * | 2011-05-27 | 2014-02-26 | 首都医科大学 | 一种具有溶血栓活性的化合物，及其制备方法和应用 |
| CN103833827B (zh) * | 2012-11-27 | 2016-08-03 | 上海医药工业研究院 | 一种酰胺类化合物、其药物组合物、制备方法及应用 |
| JP6386035B2 (ja) * | 2013-06-12 | 2018-09-05 | ヴィアメット ファーマスーティカルズ（エヌシー），インコーポレイテッド | 金属酵素阻害剤化合物 |
| CN106316975A (zh) * | 2015-06-15 | 2017-01-11 | 山东轩竹医药科技有限公司 | 酰胺类化合物及其作为tgr5激动剂的应用 |
| CN116813691B (zh) * | 2018-10-29 | 2024-04-12 | 丽珠医药集团股份有限公司 | 新的二肽类化合物及其用途 |
-
2019
- 2019-10-25 CN CN202310778549.2A patent/CN116813691B/zh active Active
- 2019-10-25 AU AU2019371209A patent/AU2019371209B2/en active Active
- 2019-10-25 CA CA3117599A patent/CA3117599A1/en active Pending
- 2019-10-25 KR KR1020217016217A patent/KR102882178B1/ko active Active
- 2019-10-25 US US17/289,379 patent/US12209141B2/en active Active
- 2019-10-25 JP JP2021547662A patent/JP7503561B2/ja active Active
- 2019-10-25 CN CN201980082261.3A patent/CN113195515B/zh active Active
- 2019-10-25 EP EP19877652.8A patent/EP3873916B8/en active Active
- 2019-10-25 WO PCT/US2019/057985 patent/WO2020092139A1/en not_active Ceased
- 2019-10-28 TW TW108138880A patent/TWI870362B/zh active
-
2021
- 2021-04-27 IL IL282676A patent/IL282676B1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7221021B2 (ja) | 毒性アルデヒド関連疾患および処置 | |
| EP1303501B1 (en) | Cyanomethyl substituted thiazoliums and imidazoliums and treatments of disorders associated with protein aging | |
| CN115515956A (zh) | 一种苯并咪唑类衍生物及其制备方法和医药用途 | |
| HUP0300544A2 (hu) | Integrin expresszálás inhibitorokat tartalmazó gyógyszerkészítmények | |
| JP2020517732A5 (OSRAM) | ||
| CN109983007A (zh) | 酰胺类衍生物抑制剂及其制备方法和应用 | |
| KR940005566A (ko) | 퀴놀린 화합물 | |
| CA2694270A1 (en) | Substituted aryloxazoles and the use thereof | |
| JP2004509117A5 (OSRAM) | ||
| RU2001107897A (ru) | Фармацевтическая композиция для лечения гепатита | |
| JP2004532250A (ja) | 線維性疾患又は他の適応症の治療方法 | |
| JP2018536641A5 (OSRAM) | ||
| RU2005123394A (ru) | Диаминовые производные | |
| RU2013125480A (ru) | Стимуляторы sgc | |
| JP2021523887A (ja) | ＸＩＩａ因子インヒビター | |
| JP2004502756A5 (OSRAM) | ||
| JP2021522327A5 (OSRAM) | ||
| WO2009087285A4 (fr) | 5,6-diaryles pyridines substitues en position 2 et 3, leur preparation et leur application en therapeutique | |
| JP2002179572A (ja) | アレルギー性眼疾患治療剤 | |
| JP2009513707A (ja) | ジアリールウレア及び併用剤 | |
| RU2003110575A (ru) | Производные пиразола, используемые в качестве ингибиторов ротеинкиназы | |
| RU2013136045A (ru) | Ингибиторы каспазы-2 | |
| NO20020917L (no) | Behandling av migrene ved administrering av en <alfa>- liponsyre eller derivater derav | |
| RU2011105161A (ru) | Новое производное индола, содержащее карбамоильную группу, уреидную группу и замещенную оксигруппу | |
| JP2024517789A5 (OSRAM) |